Moore Capital Management’s Boston Scientific BSX Stock Holding History

Moore Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$5M	–	526
2023 Q1	$5M	Buy	+100,000	New	+$4.71M	0.11%	158
2022 Q4	–	Sell	-479,888	Closed	-$18.6M	–	561
2022 Q3	$18.6M	Buy	+479,888	New	+$19.3M	0.44%	43
2022 Q2	–	Sell	-358,472	Closed	-$15.9M	–	703
2022 Q1	$15.9M	Buy	358,472 +14,330	+4%	+$621K	0.4%	41
2021 Q4	$14.6M	Buy	+344,142	New	+$14.5M	0.29%	72
2021 Q2	–	Sell	-556,409	Closed	-$21.5M	–	821
2021 Q1	$21.5M	Buy	556,409 +47,775	+9%	+$1.81M	0.27%	68
2020 Q4	$18.3M	Buy	508,634 +179,632	+55%	+$6.47M	0.2%	73
2020 Q3	$12.6M	Buy	329,002 +179,002	+119%	+$6.9M	0.24%	87
2020 Q2	$5.27M	Buy	+150,000	New	+$5.4M	0.14%	135

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Moore Capital Management's BSX Position: Q2 2023 in Review

Moore Capital Management sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 100,000 shares — an estimated $5M sold.

Moore Capital Management first reported a position in BSX in Q2 2020 and held it in 8 quarters. The position peaked at $21.5M in Q1 2021. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

Moore Capital Management reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
Moore Capital Management sold 100,000 Boston Scientific shares in Q2 2023, an estimated $5M.
Moore Capital Management first reported a position in Boston Scientific in Q2 2020 and held it in 8 quarters.
Moore Capital Management's Boston Scientific position peaked at $21.5M in Q1 2021.
1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Moore Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.